News Conference News ACC 2014 CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks L.A. McKeown March 31, 2014
News Conference News ACC 2014 Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure Yael L. Maxwell March 29, 2014
News Conference News ACC 2013 SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI Caitlin E. Cox March 12, 2013
News Conference News ACC 2013 Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES Jason Kahn March 09, 2013
News Conference News ACC 2012 ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released Yael L. Maxwell April 02, 2012
News Conference News ACC 2012 Transradial PCI Saves Money Compared with Transfemoral Access L.A. McKeown March 27, 2012
News Conference News ACC 2012 Early Cardiac CTA Improves Decision-Making in Suspected ACS L.A. McKeown March 27, 2012
News Conference News ACC 2012 Benefits of Transradial PCI May be Limited to High Volume Centers Jason Kahn March 27, 2012
News Conference News ACC 2012 ASCERT: Long-term Survival Advantage with CABG in Multivessel Disease Yael L. Maxwell March 27, 2012
News Conference News ACC 2012 Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES L.A. McKeown March 26, 2012
News Conference News ACC 2012 RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years March 26, 2012
News Conference News ACC 2012 PARTNER: TAVR Remains as Effective as Surgery at 2 Years March 26, 2012
News Conference News ACC 2012 INFUSE-AMI: Bolus Abciximab Works, Thrombus Aspiration Doesn’t for Large STEMI Jason Kahn March 25, 2012
News Conference News ACC 2012 Adjunctive Cilostazol Noninferior to Double-Dose Clopidogrel in All-Comer PCI Trial L.A. McKeown March 25, 2012
News Conference News ACC 2012 Stem Cell Therapy Fails to Show Benefit in Chronic Ischemic Heart Failure L.A. McKeown March 24, 2012
News Conference News ACC 2012 New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding L.A. McKeown March 24, 2012